Beijing SL Pharmaceutical Co., Ltd. (SHE:002038)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2019	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Jan 1, 2019	Dec 31, 2017	Dec 31, 2016
Pharmaceutical Industry	612.49M	652.74M	1.01B	1.03B	1.21B
Pharmaceutical Industry Growth	-6.17%	-35.08%	-2.68%	-14.96%	9.17%
Unallocated Others	11.15M	7.68M	12.98M	17.05M	-
Unallocated Others Growth	45.17%	-40.81%	-23.87%	-	-
Total	623.64M	660.42M	1.02B	1.05B	1.21B
Total Growth	-5.57%	-35.15%	-3.03%	-13.55%	9.17%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2019	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Jan 1, 2019	Dec 31, 2017	Dec 31, 2016
North East China	62.29M	44.99M	73.37M	76.83M	88.45M
North East China Growth	38.45%	-38.68%	-4.51%	-13.14%	-21.31%
North China	113.35M	92.04M	145.67M	170.13M	248.84M
North China Growth	23.15%	-36.82%	-14.38%	-31.63%	25.19%
East China	185.03M	208.48M	293.75M	347.30M	390.03M
East China Growth	-11.25%	-29.03%	-15.42%	-10.95%	1.77%
Central South China	167.20M	205.08M	326.86M	259.11M	333.28M
Central South China Growth	-18.47%	-37.26%	26.15%	-22.25%	16.96%
South West China	59.40M	58.53M	114.18M	124.46M	88.64M
South West China Growth	1.49%	-48.74%	-8.26%	40.41%	20.26%
North West China	32.20M	46.49M	61.07M	62.69M	61.08M
North West China Growth	-30.74%	-23.88%	-2.58%	2.64%	29.35%
Regional and Export Business	4.17M	4.81M	3.46M	9.63M	4.50M
Regional and Export Business Growth	-13.21%	38.99%	-64.10%	114.22%	-63.87%
Total	623.64M	660.42M	1.02B	1.05B	1.21B
Total Growth	-5.57%	-35.15%	-3.03%	-13.55%	9.17%

Source: S&P Global Market Intelligence.